SEARCH

SEARCH BY CITATION

References

  • Myers, B., Crouch, D., Dolan, G. (2000) Thalidomide treatment in advanced refractory myeloma. British Journal of Haematology, 111, 986.DOI: 10.1046/j.1365-2141.2000.02393-2.x
  • Rajkumar, S.V., Hayman, S., Fonseca, R., Dispenzieri, A., Lacy, M., Geyer, S., Wellik L., Lust, J., Kyle, R., Greipp, P., Gertz, M., Witzig, T. (2000) Thalidomide plus dexamethasone and thalidomide alone as first line therapy for newly diagnosed myeloma. Blood, 96, 11168a.
  • Tiplady, C.W. & Summerfield, G.P. (2000) Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma. British Journal of Haematology, 111, 381.DOI: 10.1046/j.1365-2141.2000.02372.x